Log In
Print
BCIQ
Print
Print this Print this
 

BTI-320 (formerly PAZ320)

  Manage Alerts
Collapse Summary General Information
Company Boston Therapeutics Inc.
DescriptionChewable polysaccharide that inhibits alpha glucosidase
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today